Physician profile
Anders J Brodd
NPI 1164482295
$1,011.18
in general payments reported to CMS, 2019-2025
15 companies · $277 in 2025
The $277 reported for 2025 was more than what 83% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $86.28 · 2021: $124 · 2022: $104 · 2023: $96.07 · 2024: $140 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $512.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $247.53 | 2021-2025 | Qelbree, Qelbree |
| Sanofi Pasteur INC. | $114.99 | 2019-2025 | |
| Pfizer INC. | $107.58 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $73.37 | 2019-2024 | Vaxneuvance, Gardasil 9, Vaxelis |
| Genentech USA, INC. | $67.28 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $62.30 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $60.48 | 2019-2024 | |
| Adlon Therapeutics L.P. | $49.12 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $48.71 | 2025 | Jornay Pm |
| Acadia Pharmaceuticals INC | $42.50 | 2025 | Daybue |
| Organon LLC | $39.52 | 2024-2025 | Nexplanon |
| Arbor Pharmaceuticals, INC. | $27.91 | 2019 | |
| Kaleo, INC. | $26.90 | 2022 | |
| Corium, LLC | $23.30 | 2023 | Azstarys |
| Tris Pharma INC | $19.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anders Brodd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.